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Abstract
Extracellular RNA is becoming increasingly recognized as a signaling molecule. Virally derived double stranded (ds)RNA
released into the extracellular space during virus induced cell lysis acts as a powerful inducer of classical type I interferon
(IFN) responses; however, the receptor that mediates this response has not been identified. Class A scavenger receptors (SR-
As) are likely candidates due to their cell surface expression and ability to bind nucleic acids. In this study, we investigated a
possible role for SR-As in mediating type I IFN responses induced by extracellular dsRNA in fibroblasts, a predominant
producer of IFNb. Fibroblasts were found to express functional SR-As, even SR-A species thought to be macrophage specific.
SR-A specific competitive ligands significantly blocked extracellular dsRNA binding, entry and subsequent interferon
stimulated gene (ISG) induction. Candidate SR-As were systematically investigated using RNAi and the most dramatic
inhibition in responses was observed when all candidate SR-As were knocked down in unison. Partial inhibition of dsRNA
induced antiviral responses was observed in vivo in SR-AI/II
-/- mice compared with WT controls. The role of SR-As in
mediating extracellular dsRNA entry and subsequent induced antiviral responses was observed in both murine and human
fibroblasts. SR-As appear to function as ‘carriers’, facilitating dsRNA entry and delivery to the established dsRNA sensing
receptors, specifically TLR3, RIGI and MDA-5. Identifying SR-As as gatekeepers of the cell, mediating innate antiviral
responses, represents a novel function for this receptor family and provides insight into how cells recognize danger signals
associated with lytic virus infections. Furthermore, the implications of a cell surface receptor capable of recognizing
extracellular RNA may exceed beyond viral immunity to mediating other important innate immune functions.
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Introduction
There is a ‘trinity’ of pattern recognition receptors (PRRs) used
by the innate immune system to sense pathogens. These include
the toll-like receptors (TLRs), retinoic acid-inducible gene-I (RIG-
I)-like receptors (RLRs) and nucleotide oligomerization domain
(NOD)-like receptors (NLRs) [1]. All three sensor families have
been implicated in innate antiviral responses, with members of
each family being able to recognize viral double-stranded (ds)
RNA, a pathogen associated molecular pattern (PAMP) and a
powerful inducer of both innate and adaptive immune responses.
Cellular localization of these dsRNA sensors differs; TLR3 is
endosomal while the RLRs and NLRs (RIG-I/MDA-5/LGP2 and
Nalp3 respectively) are cytoplasmic [2–4]. When dsRNA is
endosomal, TLR3 is recruited from the endoplasmic reticulum
to the endosome where it binds dsRNA and triggers intracellular
signaling pathways through a TRIF dependent mechanism [5].
RIG-I, MDA-5 and LGP2 recognize dsRNA in the cytoplasm and
while LPG2 lacks signaling capability [6], RIG-I and MDA-5
signal through interferon (IFN)-b promoter stimulator 1 (IPS-1),
an adaptor molecule associated with the mitochondria [7]. These
pathways lead to the activation of transcription factors, including
IFN regulatory factor (IRF)-3 and -7, and the induction of type I
IFNs, IFN stimulated genes (ISGs) and the establishment of an
antiviral state [8]. Nalp3 has been shown to mediate dsRNA
induced IL-1b production in macrophages, in a TLR3 indepen-
dent manner, and may play an important role in pro-inflamma-
tory responses to dsRNA [4].
Almost all viruses produce dsRNA sometime during viral
replication as either a genomic fragment, a replicative interme-
diate or by stem and loop structures [9]. Intracellular dsRNA is
generated in the virally infected cell. With resulting cell lysis this
viral dsRNA is released into the extracellular space, and being a
stable (nuclease-resistant) molecule it is able to stimulate antiviral
responses in neighboring, uninfected cells [10]. Extracellular
dsRNA has been implicated in both local and systemic toxic
reactions associated with viral infections, and is an important
modulator of both innate and adaptive antiviral immune responses
[10–12]. In the laboratory the effects of extracellular dsRNA have
been observed for many years, as exogenous synthetic dsRNA is
commonly used to experimentally induce antiviral responses.
Based on cellular localization, RLRs and NLRs are most likely to
sense intracellular dsRNA generated during a primary viral
infection. TLR3 is expressed on the cell surface of some cell types
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environments, such as acidified endosomes [14]. With the existing
‘trinity’ unable to sense extracellular ligands from the cell surface,
the outstanding question remains as to how extracellular dsRNA
triggers intracellular antiviral responses.
The characteristics of class A scavenger receptors (SR-As) make
them attractive candidates for a dsRNA surface receptor to
mediate innate antiviral immune responses. Firstly, they are
located on the cell surface [15] and can bind nucleic acids [16].
Macrophage SR-As can bind ssRNA molecules, such as poly I and
poly G as well as poly IC, a synthetic dsRNA [17]. Secondly, their
role in innate immunity is well established, as SR-As are important
sensors of bacterial PAMPs. Macrophage expressed SR-As can
bind lipopolysaccharide (LPS) and lipoteichoic acid (LTA)
molecules associated with gram negative and gram positive
bacteria, respectively [18], as well as mediate uptake of bacteria
by phagocytosis [19]. Thirdly, SR-As mediate internalization of
ligands and subsequent stimulation of intracellular pathways. SR-
As mediate uptake of antigens for MHC presentation in T cells
[20] and dsRNA molecules targeted for RNAi pathways [21].
Also, exogenous poly IC can induce TNF-a release in RAW 264.7
cells mediated by SR-As [22], and more recently, SR-As were
shown to mediate poly IC binding, entry, and induction of a pro-
inflammatory response in human epithelial cells [23]. Finally,
upon identification of novel SR-A family members, SR-A
expression is not restricted to macrophages, as once thought. To
date five different species of SR-As have been identified: SR-AI/
II/III, MARCO, SCARA3, SCARA4 and SCARA5. Human SR-
AI, -AII and –AIII are coded by a single gene and alternative
RNA splicing generates the three isoforms [16]. SR-AI/II/III and
MARCO are largely expressed on macrophages, but SR-AI/II/
III can be detected on endothelial and smooth muscle tissues and
MARCO on splenic dendritic cells [16]. SCARA3 is expressed on
normal human fibroblasts [24], and SCARA4 and SCARA5 are
expressed on endothelial and epithelial cells respectively [25,26].
With such a broad expression profile, there is likely to be a
functional SR-A at the site of most viral infections.
Cell lysis occurs frequently during the course of a viral infection,
resulting in the release of the contents of the cell, including
intracellularly generated dsRNA, into the extracellular space.
Although scavenger receptors have been shown to bind dsRNA,
there have been no associations between SR-As and the induction
of an antiviral response. This study shows that fibroblasts, non-
professional innate immune cells and important IFNb producers,
express functional SR-As. These SR-As act as cell surface
receptors for extracellular dsRNA, mediating dsRNA binding
and entry, ultimately leading to an antiviral state. An SR-A
mediated antiviral response was observed not only in vitro in both
mouse and human fibroblasts but in an in vivo murine model as
well. Once internalized by SR-As, extracellular dsRNA elicits
antiviral responses through well-characterized dsRNA receptors,
namely TLR3, RIG-I and MDA5. Clearly, SR-As play an
important role in monitoring the extracellular milieu, and should
be considered an essential accessory to TLRs, RLRs, and NLRs
for their ability to recognize extracellular dsRNA and mediate its
entry and subsequent delivery to intracellular sensors.
Results
Murine embryonic fibroblasts express functional SR-As
Fibroblasts, a non-hematopoietic cell type and key source of
IFNb in response to dsRNA [27], are a relevant cell type in which
to study antiviral responses. Therefore the expression profile of
SR-As was determined in primary murine fibroblasts. In the
absence of available antibodies for all SR-As, the expression profile
was generated using RT PCR and gene specific primers (Table 1).
The list of candidate SR-As was compiled based on their ability to
bind polyanionic ligands. These SR-As include: SR-AI, SR-AII,
MARCO, SCARA3, SCARA4 and SCARA5. SRA-III is not
expressed on the plasma membrane and is unable to bind
polyanionic ligands [28]; therefore it was not pursued as a
candidate dsRNA receptor. Despite an initial report suggesting
that SCARA3 localization is intracellular, it was included as a
candidate SR-A given its ability to bind polyanionic ligands [24].
All six SR-A transcripts tested could be readily detected in C57Bl/
6 murine embryonic fibroblasts (MEFs), while SR-A transcript
expression in balb-c MEFs was more restricted (Figure 1A).
Primary murine lung fibroblasts were found to express all
candidate SR-As with the exception of SCARA5. RAW 264.7, a
murine monocyte/macrophage cell line, was found to express SR-
AI and –AII but not MARCO, as previously described [29,30]. To
our knowledge, expression of SCARA4 transcript is a novel
finding for this cell line. Primary murine splenocytes showed levels
of expression of all SR-A transcripts. This population of cells
would contain those of myeloid lineage, acting as a positive control
for SR-A expression. These data suggest that the expression of SR-
As at the transcript level is more ubiquitous than previously
appreciated.
Expression of functional SR-As was determined by investi-
gating acetylated low- density lipoprotein (AcLDL) binding.
AcLDL is a well-characterizedl i g a n df o rS R - A I ,– A I Ia n d
MARCO [16] but not SCARA4 [25] or SCARA5 [26]. To our
knowledge, SCARA39s ability to bind AcLDL has yet to be
elucidated. MEFs derived from C57Bl/6 mice were able to bind
and take up fluorescently labeled AcLDL (Figure 1B). MEFs
derived from balb-c MEFs could also take up AcLDL, but with a
lower efficiency (data not shown). The binding of AcLDL was
blocked by treatment with SR-A specific competitive ligands,
fucoidin and dextran sulfate (DxSO4), but not their non-
competitive counterparts, fetuin and chondroitin sulfate
(ChSO4). Interestingly, poly IC, a synthetic dsRNA molecule,
was able to inhibit AcLDL binding to a level of inhibition
similar to the classic SR-A ligands. DsRNA mediated inhibition
was not limited to poly IC, as in vitro transcribed dsRNA of
different lengths inhibited AcLDL binding with similar efficien-
cy (data not shown). A dsDNA molecule, poly dA:dT could
Author Summary
Nearly all viruses produce dsRNA during their replication
cycle. This molecule is not normally found in a healthy host
cell and thus functions as a flag, alerting the host to a viral
infection. Cells can die by lysis during virus infections, and
the intracellular dsRNA is then released into the extracel-
lular space. This dsRNA is stable in the extracellular milieu,
and is able to function as a signaling molecule, detected
by neighboring cells. This has been observed experimen-
tally, as extracellular dsRNA has been used for years to
trigger host antiviral responses. It has also been suggested
that extracellular dsRNA plays a role in causing patholog-
ical symptoms in virus infected patients. Our data suggests
that class A scavenger receptors (SR-As) function as cell
surface receptors for dsRNA. SR-As bind extracellular, viral
dsRNA and mediate its entry into the cell, where it delivers
the dsRNA to other known intracellular dsRNA sensors,
activating intracellular antiviral responses. These findings
shed new light on how the host detects and responds to
virus infection.
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a fluorescence plate reader assay, was inhibited by poly IC,
fucoidin and DxSO4,b u tn o tf e t u i no rC h S O 4, in a statistically
significant manner (Figure 1C). Inhibition by poly dA:dT was
statistically significant but clea r l yn o ta se f f e c t i v ea sd s R N Aa n d
the classic SR-A ligands.
SR-As mediate dsRNA binding, entry and subsequent ISG
expression
As dsRNA was able to block AcLDL binding and uptake, the
possibility that SR-As mediate extracellular dsRNA entry was
investigated. DsRNA molecules were derived by in vitro
transcription based on randomly selected West Nile virus
genome sequences. Two lengths were used to reveal any
differences in binding efficiencies, which had previously been
observed with other dsRNA sensors. In the absence of the
competitive ligands fluorescently labeled dsRNA was found to
associate with the MEFs (Figure 2A). Fucoidin blocked dsRNA
cell association, while fetuin did not. Similar results were
observed with DxSO4 and ChSO4 (data not shown). Further-
more, dsRNA entry was quantified using a fluorescence plate
reader assay (Figure 2B). Corroborating the observations made
by fluorescence microscopy, it was found that fucoidin almost
completely blocked dsRNA binding and uptake while at the
same concentration fetuin did not. These results were similar
between the two dsRNA lengths tested. Balb-c MEFs were
also able to bind fluorescently labeled dsRNA (both v200
and v1000), which was blocked by fucoidin but not fetuin
(Figure S1).
The mechanism of dsRNA entry was investigated using
pharmacological inhibitors. Cells were pre-treated with chlor-
promazine, a clathrin-mediated endocytosis inhibitor [31],
cytochalasin D, an actin polymerization inhibitor [32], and
bafilomycin A1, a specific V-H-ATPase inhibitor [21], for 30
minutes. Cells were then treated with v1000 for 2h in the presence
of the inhibitors. Transcript levels of IP10, an early ISG, were used
as an indicator of dsRNA effects within the cell (Figure 2C).
Chlorpromazine blocked induction of IP10 transcript expression
in a concentration dependent manner; while bafilomycin A1 did
not alter levels when compared to v1000 alone. Although not
statistically significant, cytochalasin D had a general suppressive
effect that was concentration independent. No changes in cell
viability were detected with any of the inhibitors using the
fluorescent cell viability dyes alamar Blue and CFDA-AM (data
not shown). These data suggest that similar to other ligands, SR-A
mediated dsRNA entry occurs by clathrin mediated endocytosis.
The inhibition of dsRNA entry in the presence of SR-A specific
competitive ligands corresponded with a decrease in ISG
induction as measured by real time RT-PCR (Figure 2D). ISG
transcripts were measured in C57Bl/6 MEFs treated with v1000
for 4h in the presence or absence of DxSO4, fucoidin, or fetuin
after a 30 minute pretreatment with the inhibitors alone. DxSO4
blocked induction of ISG15, IRF-7 and ISG56 transcripts by
v1000 in a concentration dependent manner. Though not
statistically significant for ISG15 and IRF-7, similar results were
observed with fucoidin. DxSO4 (10 mg/mL) was able to com-
pletely inhibit v1000 induced IFN-b induction while fucoidin
(100 mg/mL) reduced IFN-b induction but could not block it
completely (data not shown). It is this small amount of IFN that is
likely responsible for the increased ISG induction observed with
v1000 and fucoidin. Treatment with fetuin, the corresponding
non-competitive compound, did not affect ISG transcript
expression. Thus, SR-As appear to be the chief mediator of
extracellular dsRNA binding, entry and resulting ISG induction in
MEFs.
SR-As compensate for one another with regards to
dsRNA binding
SR-A species were knocked down individually and in combi-
nations by siRNA to determine whether specific SR-As were
responsible for binding extracellular dsRNA. MEFs derived from
balb-c mice were used as they bound dsRNA similar to C57Bl/6
derived MEFs but do not express SR-AII and MARCO, removing
these two SR-As as possible individual candidates. Pre-validated
siRNA oligos were used to knock down SR-AI, SCARA3,
SCARA4 and SCARA5. The SR-AI oligo sequence and
downstream real time PCR primers target the SR-AII species as
well; therefore the siRNA knockdowns using this oligo are
reported as SR-AI/II. Following knockdown, dsRNA binding,
entry and ISG induction were measured. No effects were observed
when individual SR-As were knocked down; SR-AI/II results are
shown as a representative of results observed by single knock-
Table 1. Primer sequences used for amplifying scavenger receptor transcripts by RT-PCR.
Species Gene Accession number Sense Primer (59R 39) Antisense Primer (59R 39) PCR product length (bp)
Murine SR-AI NM_031195 AGAAGAACAAGCGCACGTGG CCCAACAGCACCCAGGGTTA 578
SR-AII NM_001113326 GACACGGAACGCTTCCAGAA AGCCCGTATATCCCAGCGAT 750
MARCO NM_010766.2 CTCCGTCAGCAGTTCAACAA TCCAGGTTTTCCTTGGTCAC 516
SCARA3 NM_172604 TGCTATGATGTCAAGGCTGC GATCATGGAGAGGTTTCGGA 666
SCARA4 AB038519 CAGCAGGTTTTCCTTCAAGC TTCTTGATGAGCTGACCGTG 578
SCARA5 NM_028903 CTGAGACCAGGTTCCCATGT AAAAATACCGCCGTTAGCCT 865
Human SR-AI NM_138715 GACATGGAAGCCAACCTCAT CCAAGCTCCTACAGACGACC 787
SR-AII NM_002445 TCGAGGACTCCCAGGATATG GGCAGAGAACTGAGGACTGG 446
MARCO NM_006770 CAACAAGCTGCTTTTCACCA ACATCCCTGGGTTCTGAGTG 382
SCARA3 variant 1 NM_016240 ACGAGATTGAAATTGGCACC CCCTCATTGGAATCAGAGGA 877
SCARA3 variant 2 NM_182826 TGCAGCTGGATAACATCTCG CTTGGTCATCCTGGGCTTTA 510
SCARA4 NM_130386 CTGCGGACGCTGACCAGCAA GTGAGGCGGGCAGCCATTGT 762
SCARA5 NM_173833 CTCTTGAACATGTGCTCCGA TCACTTGACGTTGCCTCTTG 315
doi:10.1371/journal.ppat.1000829.t001
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candidate SR-As were knocked down in combination (Figure 3).
When SRAI/II, SCARA3, SCARA4 and SCARA5 were knocked
down together (Figure 3D) binding of fluorescently labeled dsRNA
was blocked considerably as observed by fluorescence microscopy
(Figure 3A). The negative control (non-targeting negative control
pool) did not affect dsRNA binding (data not shown). A statistically
significant decrease in dsRNA entry (Figure 3B) and downstream
ISG induction (Figure 3C) was also observed. As an effect was only
observed when all relevant SR-As were knocked down, these data
suggest that SR-As have a remarkable ability to compensate for
one another.
Antiviral responses are impaired in SR-AI/II knockout
mice
A role for SR-As in dsRNA-induced antiviral responses was
studied in vivo using SR-AI/II
-/- mice [33]. By RT-PCR it was
determined that all candidate SR-As were present at the
transcript level in whole lung tissue from WT mice (Figure 4A).
SRA-I/II
-/- mice have a disruption at exon 4, which is essential
for trimerization of the receptor [33]. The forward primer for
SR-AII in our expression panel falls in exon 4 (the reverse in
exon 10) while the SR-AI primers are specific for sequences in
exons 5 and 10. Thus the SR-AI/II
-/- mice showed expression of
MARCO, SCARA3, SCARA4 and SCARA5 and disruption of
SRAI/II as expected. Both WT and SR-AI/II
-/- mice were
treated with PBS or poly IC (50 mg) by intranasal administration.
At 12 h post-treatment, type I IFN bioactivity was measured in
broncho-alveolar lavage fluid (BALF). Naı ¨ve MEFs were treated
with BALF diluted in growth media and after 24 h cells were
challenged with a VSV-GFP infection. There was a statistically
significant difference in antiviral responses between WT and
SRAI/II
-/- BALF as determined by serial dilution, suggesting
less type I IFN was produced in poly IC treated SRAI/II
-/- mice
compared with WT mice (Figure 4B). No antiviral activity was
detected in BALF from PBS treated mice (data not shown). Poly
IC also induced lower levels of ISG transcripts (IP10, ISG56 and
ISG15) in knockout mice when compared to WT mice, as
Figure 1. Primary murine fibroblasts express functional SR-As. (A) SR-A transcripts were detected using RT-PCR and primers specific to SR-AI
(lane I), SR-AII (II), MARCO (M), SCARA3 (3), SCARA4 (4), and SCARA5 (5) in murine embryonic fibroblasts (MEFs) derived from C57Bl/6 or balb-c mice,
the macrophage-like cell line RAW 264.7, and primary lung fibroblasts and splenocytes derived from C57Bl/6 mice. GAPDH was used as an internal
control for all cell types (G). (B) Cell associated AcLDL was observed by live-cell fluorescence microscopy in MEFs derived from C57Bl/6 mice treated
with Alexafluor 488 labeled AcLDL for 1h (2.5 mg/mL), in the presence or absence of SR-A competitive ligands (fucoidin, DxSO4), their corresponding
non-competitive counterparts (fetuin, ChSO4) or nucleic acids (poly IC, poly dA:dT) all at 100 mg/mL. Magnification 200X. (C) AcLDL entry was
measured using a fluorescence plate reader assay. Cells were treated with Alexafluor 488 labeled AcLDL (2.5 mg/ mL) for 1h in the presence of poly IC
(pIC), fucoidin (fuc), fetuin (fet), DxSO4, ChSO4 or poly dA:dT (100 mg/mL). Cells treated with AcLDL alone were set at 100% fluorescence. These data
include three independent experiments 6 SEM. Statistical analysis was performed by a one-way ANOVA with Tukey post test (* p,0.05, *** p,0.001).
doi:10.1371/journal.ppat.1000829.g001
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mediated endocytosis. (A) Cellular binding of viral dsRNA was observed by fluorescence microscopy in MEFs derived from C57Bl/6 mice treated
with either 200 bp or 1000 bp Alexafluor 488 labeled viral dsRNA (v200 or v1000 respectively, both at 1 mg/mL) for 1h, in the presence or absence of
fucoidin or fetuin (both at 100 mg/mL). Cells were fixed and nuclei counterstained with Hoechst 33258. Magnification 400X. (B) Fluorescently labeled
dsRNA entry was quantified using cells treated with Alexafluor 488 labeled v200 or v1000 (both at 1 mg/mL) for 1h in the presence of fucoidin or
fetuin (both at 100 mg/mL). Cells treated with dsRNA alone (dsRNA) were set at 100% fluorescence. These data include three independent
experiments 6 SEM. Statistical analysis was performed by a one-way ANOVA with Tukey post test (*** p,0.001) (C) MEFs were treated with v1000
(1 mg/mL) for 2h in the presence of endocytosis pathway inhibitors, chlorpromazine (CP), cytochalasin D (cyto D) and bafilomycin A1 (Baf A). IP10
transcript levels were measured using real time PCR and reported as a fold change difference from mock treated cells (ctrl), whose fold change was
set to 1. These data are the average of three independent experiments 6 SEM. Statistical analysis was performed by one-way ANOVA with a
Dunnett’s post test using v1000 as the control comparison, * p,0.05 (D) ISG15, IRF-7 and ISG56 transcript levels were measured by real time PCR in
C57Bl/6 MEFs treated with viral dsRNA (v1000, 0.5 mg/mL) for 4 h in the presence or absence of dextran sulfate (DxSO4), fucoidin (Fuc.) or fetuin (Fet.).
These data are the average of three independent experiments 6 SEM. Statistical analysis was performed by one-way ANOVA and a Dunnett’s post
test, comparing all treatments to v1000 alone, ** p,0.01.
doi:10.1371/journal.ppat.1000829.g002
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decrease was observed with IP10, all three genes tested showed
statistically significant decreases in transcript levels when
compared with WT (Figure 4C). These data show that SR-AI/
II plays a role in mediating antiviral responses induced by
exogenous dsRNA in vivo. This inhibition is partial, which would
be expected considering the presence of other SR-As within the
lung.
Figure 3. dsRNA binding is dependent on all candidate SR-A family members. DsRNA binding, entry and subsequent induction of ISGs was
measured in balb-c derived MEFs treated with media alone (OM), Dharmafect alone (DF), SR-AI/II specific siRNA (I/II) or a combination of SR-AI/II,
SCARA3, SCARA4 and SCARA5 siRNA oligomers (-I/II,3,4,5) for 24h. (A) Binding of dsRNA was measured in MEFs treated with SR-A siRNA for 24h
followed by Alexafluor 488 labeled v1000 (1 mg/mL) for 1h. Nuclei were counterstained with Hoechst 33258. Magnification 400X. (B) Entry of
Alexafluor 488 labeled v1000 was measured by fluorescence plate reader, in balb-c MEFs treated with siRNA for 24h followed by 1h treatment with
fluorescently labeled v1000 (1 mg/mL). Results are reported as a % of DF alone (set to 100%). These data include three independent experiments and
are reported as an average 6 SEM. Statistical analysis was performed by a one-way ANOVA with a Dunnett’s post test, with DF being the control
comparison (** p,0.01). (C) Levels of ISG56 and IP10 transcript expression were measured by real time PCR in balb-c MEFs treated with SR-A siRNA
for 24h followed by stimulation with 1 mg/mL v1000 for 6 h. Results are reported as a fold change difference from DF treated cells (DF), whose fold
change was set to 1. These data include three independent experiments and are reported as an average 6 SEM. Statistical analysis was performed by
a one-way ANOVA with a Dunnett’s post test, with DF being the control comparison (* p,0.05). (D) SR-A transcript levels were measured by real time
PCR in balb-c MEFs treated with SR-A siRNA for 24h. Results are reported as a fold change difference from DF treated cells (DF), whose fold change
was set to 1. These data include three independent experiments and are reported as an average 6 SEM. Statistical analysis was performed by a one-
way ANOVA with a tukey’s post hoc test (* p,0.05, ** p,0.01).
doi:10.1371/journal.ppat.1000829.g003
Figure 4. SR-As are involved in dsRNA induced antiviral responses in vivo. (A) SR-A expression was measured at the transcript level in both
wild type (WT) and SR-AI/II
-/- mouse whole lungs using RT-PCR and primers specific to SR-AI (lane I), SR-AII (II), MARCO (M), SCARA3 (3), SCARA4 (4),
SCARA5 (5) and GAPDH (G). (B) Poly IC treated mice were sacrificed 12h post-treatment and type I IFN bioactivity in the BALF was determined by
antiviral assay. Data is presented as % VSV replication at the indicated BALF dilutions. The absence of VSV replication indicates the presence of type I
IFN in BALF. Statistical analysis was performed using a one-way ANOVA with a tukey’s post hoc test (* p,0.05). (C) IP10, ISG56 and ISG15 transcript
levels in the lung of poly IC treated WT and SR-AI/II
-/- mice were measured 12h post treatment. Results are reported as a fold change comparison with
PBS treated WT or SR-AI/II
-/- mice. Statistical analysis was performed using a t test; *** p,0.001, * p,0.05. Data show one representative experiment
and are reported as means 6 SEM, n=4.
doi:10.1371/journal.ppat.1000829.g004
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dsRNA PRRs
A functional role for SR-As is to act as a carrier, delivering
ligands to downstream pathways [16]. SR-A delivery of extracel-
lular dsRNA to intracellular sensors was investigated in MEFs
deficient for the classic intracellular dsRNA PRRs, TLR3, RIG-I
and MDA5, as well as their downstream adapter molecules, TRIF
or IPS-1. An antiviral assay was performed whereby cells treated
with a range of dsRNA concentrations for 6h were infected with
VSV-GFP and the resultant fluorescence, representing viral
replication, was quantified 24h pi (Figure 5). The antiviral
response to extracellular dsRNA was similarly reduced in TLR3
and TRIF null MEFs relative to WT MEFs (Figure 5A). Poly IC
induced antiviral responses were significantly reduced in both
RIG-I and MDA5 null MEFs, with a greater inhibition observed
in MDA5
-/- MEFs. Poly IC induced responses were also inhibited
in IPS-1
-/- MEFs, which corroborates the receptor data, as both
RIG-I and MDA5 signal through IPS-1 (Figure 5B). The poly IC
used in this study is a mixture of dsRNA molecules with varying
lengths, with an average of 4000 bp and a range between 400 bp
and .6000 bp (data not shown). As dsRNA recognition is length
dependent [2], a dsRNA molecule of a defined length was
included to ensure that SR-As delivered extracellular dsRNA to
the appropriate intracellular PRR. Antiviral responses induced by
v200, an in vitro transcribed dsRNA molecule 200 bp in length,
were completely dependent on RIG-I and independent of MDA5
(Figure 5C). These results suggest that extracellular dsRNA
induced antiviral responses are mediated by both TLR3 and the
RLRs in a length dependent manner.
SR-As mediate dsRNA entry in human fibroblasts
To assess whether SR-As mediate dsRNA entry in human
fibroblasts, SR-A responses were investigated in a primary human
fibroblast cell type (HEL). SR-AI, SCARA3 variant 1 and 2 and
SCARA4 could be detected at the transcript level using RT PCR
(Figure 6A). For comparison purposes, SR-A transcript levels were
also investigated in 293, a human embryonic kidney cell line, and
in primary human peripheral blood mononuclear cells (hPBMCs).
293 cells were found to express SCARA3 variant 1 and 2 as well as
SCARA4 and SCARA5 at the transcript level, while hPBMCs
express MARCO and SCARA3 variant 1 and 2. A cloned hSR-
AII sequence acted as a positive control for the SR-AII primers.
Further study in HEL cells showed that an SR-A protein (,70
kDa) could be detected from whole cell extracts using a polyclonal
antibody specific to the SR-A collagenous domain (Figure 6B).
Binding of fluorescently labeled dsRNA (v1000) was observed by
fluorescence microscopy. As with murine fibroblasts (Figure 2A),
extracellular dsRNA binding was blocked by fucoidin but not
fetuin (Figure 6C). Furthermore, the anti-human SR-A polyclonal
antibody blocked v1000 binding, while the normal goat serum
(ngs) control did not. DsRNA-induced IP10 transcript expression
was inhibited 75.9464.71% (n=3) by the anti-human SR-A
antibody compared with the ngs control, as measured by real time
PCR (data not shown). It should be noted that human fibroblasts
were able to bind AcLDL with moderate efficiency, similar to
balb-c MEFs (data not shown). These results suggest that human
fibroblasts express SR-As that mediate dsRNA binding and
downstream ISG induction, similar to murine fibroblasts.
Discussion
It is well established that dsRNA is a potent signaling molecule
and modulator of innate immune responses. Extracellular dsRNA
plays an important role in these functions; however, its mechanism
of signaling intracellular antiviral pathways has remained largely
unknown. In this study we propose that SR-As function as surface
receptors for dsRNA, mediating its entry into the cell and delivery
to known intracellular PRRs, resulting in downstream type I IFN
and ISG production. There is already a precedent for SR-As
binding dsRNA. In the 1980s it was found tfhat SR-As expressed
by macrophages could bind poly IC [17]. The novelty of this study
is threefold. Firstly, this study demonstrates that SR-A expression
is broader than previously appreciated. Secondly, the present
study shows that ligand binding by SR-As is compensatory.
Thirdly, these data show that SR-As are essential mediators of
extracellular dsRNA induced antiviral responses. The implications
of these data are important for understanding both viral
pathogenesis and host responses.
To our knowledge, this study represents the most complete
examination of all known class A scavenger receptors within one
cell type. MEFs were studied because they are commonly used for
investigating antiviral responses in vitro, particularly when using
knockout mice. Also, fibroblasts are an important producer of
IFNb, which is a key modulator of innate immune responses [27].
In this study we found that transcript levels of almost all candidate
SR-As were high in MEFs and primary adult lung fibroblasts, even
SR-As such as SR-AI, -AII and MARCO, whose expression was
thought to be restricted to macrophages. Furthermore, C57Bl/6
derived MEFs were able to bind AcLDL, a ligand specific to SR-
AI/II and MARCO. As expected, AcLDL binding was blocked by
the SR-A competitive ligands fucoidin and DxSO4, but not the
corresponding non-competitive ligands, fetuin and ChSO4.
Considering the present data, fibroblasts should now be included
as an SR-A expressing cell type, therefore extending expression of
SR-As to another non-immune cell type, and further expanding
their potential influence in innate immune responses.
The ability of poly IC to compete with AcLDL for binding at
the cell surface suggested that dsRNA was binding an SR-A. This
hypothesis was investigated using fluorescently labeled in vitro
transcribed dsRNA. Determined by microscopy and a fluores-
cence plate reader assay, dsRNA of both 200bp and 1000bp
lengths (v200 and v1000) bound to cells. The SR-A competitive
ligands fucoidin and DxSO4 almost completely displaced fluores-
cently labeled dsRNA binding and entry in C57Bl/6 MEFs while
their non-competitive counterparts, fetuin and ChSO4 did not.
The competitive ligands also inhibited downstream ISG induction.
Similar results were previously observed in human epithelial cells,
where poly IC binding and down stream induction of pro-
inflammatory cytokines was displaced by the SR-A competitive
ligands DxSO4 and fucoidin, but not fetuin and heparin (another
non-competitive SR-A ligand) [23]. With regards to dsRNA entry,
it is known that SR-As enter cells through an endocytic pathway
[16], and it has been shown that SR-A mediated gene expression
was dependent on endocytosis in macrophages [34]. The
pharmacological inhibitor data with chlorpromazine suggests that
dsRNA entry appears to be an active process through clathrin-
mediated endocytosis. The suppressive quality of cytochalasin D,
though not statistically significant, hints at a role for actin in
dsRNA uptake. The inability of bafilomycin A1 to completely
block dsRNA-mediated ISG induction suggests that SR-A-
mediated binding and uptake of dsRNA are independent of
endosomal acidification, suggesting a component of extracellular
dsRNA mediated ISG induction is TLR3 independent. These
entry characteristics are the same as those found with poly IC
acting as an SR-A ligand in RAW 264.7 cells. Poly IC induced
TNF-a production required internalization by clathrin coated pit
formation and actin polymerization, but not endosomal acidifica-
tion [22]. In a more recent study, dsRNA entry was found to be
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dendritic cells [35]. These data suggest that SR-As are the chief
surface receptors for extracellular dsRNA and that these receptors
are mediating dsRNA entry by clathrin mediated endocytosis
resulting in subsequent ISG induction.
As there were multiple candidate SR-A species that could act as
a surface receptor for dsRNA, siRNA was used to knock down
each species to investigate their role in dsRNA binding. Effects
were investigated in balb-c MEFs as they were found to bind
dsRNA similarly to C57Bl/6 MEFs but have a more restricted SR-
A expression profile, expressing only SR-AI, SCARA3, SCARA4
and SCARA5. No effect was observed when individual SR-As
were knocked down and the most significant effects were observed
when all SR-As were knocked down together (Figure 3). With
significant knock down of all present SR-As there was a statistically
significant decrease in dsRNA binding, entry and ISG induction.
These data suggest that no individual SR-A is responsible for
binding dsRNA, and that all candidates if present can compensate
for one another with regards to binding extracellular dsRNA. This
conclusion is not unexpected, as all known SR-As, with the
exception of SR-AIII, contain a collagenous structure, which is
responsible for binding polyanionic ligands such as nucleic aids
[28]. From the neutralization studies in human fibroblasts it is
likely that SR-As bind extracellular dsRNA via their collagenous
domain. Knock down using siRNA was not complete and as the
minimal levels of SR-A expression required to mediate binding
and uptake of dsRNA is unknown, residual levels of SR-A
expression could explain the partial inhibition observed. As new
SR-As are continually being discovered (SCARA5 was identified in
2006) it is also likely that other, yet to be identified SR-A members
could be present and binding extracellular dsRNA.
SR-As also mediated dsRNA induced antiviral responses in vivo.
When mice were treated with poly IC by intranasal administra-
tion, SRAI/II
-/- mice showed less type I IFN production and
lower ISG transcript levels when compared with their WT
counterparts. This inhibition was partial, which would be
expected, as MARCO, SCARA3, SCARA4 and SCARA5
transcripts could all be detected in the lung. Similar results have
been previously reported with regards to the inflammatory
response; poly IC treated SRAI/II
-/- mice demonstrated lower
levels of infiltrating polymorphonuclear leukocytes and lower
transcript levels of pro-inflammatory cytokines when compared to
WT controls [23]. These data show that SR-A mediated antiviral
responses to extracellular dsRNA are not limited to fibroblasts but
are involved in complex systems as well. It is likely that one cell
type is not solely responsible for the inhibitory effect observed in
vivo. It is possible that SR-As in the lung epithelium, in
combination with SR-As on recruited immune cells, could
collectively be responsible for sensing extracellular dsRNA and
mediating the observed antiviral response.
SR-As can act as carriers, bringing ligands to intracellular
signaling pathways [16]. As SR-As appear to have an essential role
in dsRNA uptake into the cell via endocytosis, the question arises
as to the mechanism of dsRNA signaling once inside the cell.
Considering the role of SR-As as a carrier, it has been previously
shown that SR-As can cooperate with TLRs. SR-As are able to
mediate apoptosis in a TLR4-dependent manner [36] and
MARCO can deliver CpG DNA to endosomal TLR9 [37]. The
present data suggest that SR-As may be delivering extracellular
dsRNA to endosomes to be recognized by TLR3. The antiviral
response was not completely inhibited in TLR3
-/- and TRIF
-/-
MEFs, however, suggesting that there is a TLR3/TRIF





inhibition in antiviral responses compared with WT. As the poly
IC preparation used in this study contains mostly larger dsRNA
molecules, the antiviral response was more dependent on MDA5
than RIG-I. As expected, the antiviral response to a short dsRNA
molecule of defined length was dependent on RIG-I but not
MDA-5. There was even greater dependence on IPS-1, the
adapter molecule utilized by both the RLRs. These data
demonstrate that extracellular dsRNA signals through cytoplasmic
dsRNA sensors. These data are similar to data reported in vivo with
poly IC treated IPS-1
-/- and TRIF
-/- mice. The extracellular
dsRNA (poly IC injected i.p. without a lipid based transfection
reagent) induced type I IFNs and ISGs (IP10), which were partially
inhibited in TRIF
-/- mice but completely abrogated in IPS-1
-/-
mice [38].
Therefore, we propose a mechanism of action whereby surface
expressed SR-As mediate the entry of extracellular dsRNA via
clathrin-mediated endocytosis (Figure 7). Once within the
endosome, dsRNA can be detected by TLR3, which would
activate a TRIF-dependent antiviral response. In addition, the
cytoplasmic sensors RIG-I and MDA-5 play an important role in
mediating antiviral responses to extracellular dsRNA. It is
currently unclear, however, how dsRNA within the endosome
becomes available to cytosolic sensors. While we cannot formally
exclude the possibility that SR-As directly interact with the
adaptor molecules TRIF and IPS-1, our data suggest that SR-As
predominantly function as carriers to deliver dsRNA to TLR3,
RIG-I and MDA-5. Furthermore, there is a possibility that SR-As
are capable of influencing the antiviral response independent of
TLRs and RLRs. We recently found that an antiviral state can be
established with high poly IC concentrations independent of IPS-1
and the downstream transcription factor IRF3 [39]. SR-A ligand
binding causes tyrosine phosphorylation of phospholipase C-c1
(PLC-c1) and phosphatidylinositol 3-kinase (PI 3-kinase) activa-
tion, as well as activation of pathways involving protein kinase C
(PKC) and mitogen-activated protein kinases (MAPKs) [16]. The
mechanisms behind these signaling pathways and the link between
endosomal dsRNA and cytosolic sensors are currently under
investigation.
The data in this study demonstrate an essential role for SR-As in
mediating dsRNA entry, but the downstream signaling capabilities
of the SR-As remain unclear. It is possible that instead of being
limited to functioning as a delivery system, SR-As could function
as pattern recognition receptors in their own right, modulating
antiviral responses similar to the trinity of PRRs. A legitimate
pattern recognition receptor can discriminate between self and
non-self, with high specificity. The trinity of dsRNA PRRs does
this through specific cellular localization and ligand binding
specificities. It could be argued that SR-As would be able to
discern self vs. non-self based on cellular localization as well. Being
surface receptors, SR-As sense extracellular nucleic acids, which
Figure 5. DsRNA induced antiviral responses are mediated by TLR3 and the RLRs. MEFs derived from (A) wild type C57Bl/6 (WT), TLR3
-/-,
TRIF
-/- and (B) WT, RIGI
-/-, MDA5
-/- and IPS-1
-/- mice were treated with serially diluted nM concentrations of poly IC for 6 h. (C) To compare length
effects, WT, RIGI
-/- and MDA5
-/- MEFs were treated with serially diluted nM concentrations of in vitro transcribed dsRNA (v200). Cells were then
challenged with VSV-GFP (MOI=0.1) and GFP fluorescence intensity was measured at 24h pi. Data is reported for each dsRNA concentration tested as
a % of VSV replication in mock treated cells. These data include three independent experiments and are reported as an average 6 SEM.
doi:10.1371/journal.ppat.1000829.g005
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such as pathogen-mediated cell lysis. With regards to specificity, a
study investigating SR-A ligand characteristics showed that SR-As
do not bind ligands based solely on their charge [17]. This study
reports that multiple negative charges are a necessary but not
sufficient requirement for SR-A binding [17]. In fact, within RNA
species, some polypurines demonstrate high affinity for SR-AI/II
(polyinosinic acid, polyguanylic acid) while other polypurines do
not (polyadenylic acid). In the present study it was found that a
negatively charged nucleic acid, poly dA:dT (dsDNA) only
partially inhibited AcLDL binding. These data show a preference
for specific polyanionic nucleic acids, a specificity that is poorly
understood. Another characteristic of a dsRNA PRR would be its
conservation between species, and preliminary evidence suggests
Figure 6. Human fibroblasts express SR-As that mediate dsRNA binding via the collagenous domain. (A) SR-A transcripts were detected
in primary human fibroblasts (Hel) using RT-PCR and primers specific to SR-AI (lane I), SR-AII (II), MARCO (M), SCARA3 variant 1(3v1), SCARA3 variant 2
(3v2), SCARA4 (4), and SCARA5 (5). SR-A transcripts detected from immortalized human embryonic kidney cells (293) and primary human peripheral
blood mononuclear cells (hPBMCs) were included for comparison purposes. (B) SR-A expression at the protein level was measured in human
fibroblasts by western blot analysis using a whole cell extract (WCE). A single band ,70kDa in size was detected. (C) Alexafluor 488 labelled v1000
(1 mg/mL) binding was observed in HEL cells by fluorescence microscopy with or without pre-treatment with the SR-A competitive ligand fucoidin or
fetuin, its non-competitive counterpart (both at 100 mg/mL). Also, v1000 binding was monitored in the presence of the anti-human SRA antibody
(aSRA) and a normal goat serum (ngs) control (both diluted at 1:50).
doi:10.1371/journal.ppat.1000829.g006
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induction in both human and murine fibroblasts. Although
hypothetical at this point, the possibility that SR-As function as
a dsRNA PRR modulating antiviral responses independent of
TLRs, RLRs and NLRs is intriguing and is currently under
investigation.
A surface receptor for dsRNA also changes the perspective on
extracellular dsRNA. The idea that RNA can act as an extracellular
signaling molecule opens many possibilities not only for antiviral
responses but also other aspects of innate immunity. DsRNA is a
remarkably stable nucleic acid, able to withstand host nuclease
activity [10]. With the existence of an extracellular dsRNA
receptor, it is possible that dsRNA could act in a paracrine fashion
to induce an antiviral state in neighboring cells. RNA as a ‘danger
signal’ may in fact not be limited to viral infections. Tens of
thousands of long non-coding (nc)RNAs, RNAs longer than 200
nucleotides, are present in mammalian cells [40]. If a cell dies in an
uncontrolled manner, whether it is virus induced or by another
stimulus, the contents of the cell, including these ncRNAs, would be
introduced into the extracellular space and subsequently detected
by neighbouring cells through their SR-As. Recently evidence for
this hypothesis has been found in mice, where necrotic cell death
stimulated TLR3 activation and subsequent inflammation, inde-
pendent of viral infection [41]. As an alternative to RNA ligands,
recently it has been shown that the dsRNA binding receptor in
dendritic cells can also bind CpG ODNs, suggesting that the SR-As
could mediate recognition of this important bacterial PAMP [35].
These ideas require further investigation but suggest that SR-As




All animals were handled in strict accordance with good animal
practice as defined by the Canadian Council for Animal Care, and
all animal work was approved by the McMaster Animal Research
Ethics Board.
Cells and materials
Polyinosinic/polycytidylic acid (poly IC) was purchased from
GE Healthcare (Buckinghamshire, UK). Chlorpromazine hydro-
Figure 7. Proposed model of SR-A-mediated antiviral activity. Lytic viral infections lead to dsRNA in the extracellular environment. (1) Surface
expressed SR-As bind extracellular dsRNA and facilitate entry via clathrin-mediated endocytosis. (2) Endosomal TLR3 binds dsRNA and induces an
antiviral response via TRIF. (3) dsRNA escapes the endosome and is detected in the cytoplasm by the RLRs RIG-I and MDA5, which induce an antiviral
response via IPS-1. (4) While the carrier function of SR-As is likely the dominant mode of action, the direct contribution of SR-As to antiviral immunity
by binding to TRIF and IPS-1 or by inducing independent, non-classical antiviral responses cannot be ruled out.
doi:10.1371/journal.ppat.1000829.g007
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chondroitin sulfate, fucoidin, fetuin, and polydeoxyadenylic
acid
.polythymidylic acid (dA:dT) were purchased from Sigma
(Oakville, Canada). Real-time PCR Taqman probes for murine
ISG15, IRF-7, ISG56, IFNb, IP10, SR-AI/II, SCARA3-5,
GAPDH and human IP10 and GAPDH were purchased from
Applied Biosystems (Streetsville, Canada). SiRNA oligomers
against SR-AI/II, SCARA3-5, a non-targeting negative control
pool, and the Dharmafect transfection reagent were all purchased
from Dharmacon (Lafayette, CO). The anti-human SR-A
antibody was purchased from Millipore (Billerica, MA). Vesicular
stomatitis virus expressing green fluorescent protein (VSV-GFP;
kindly provided by B. Lichty) was propagated on Vero cells
(ATCC).
Murine embryonic fibroblasts (MEFs) were derived from





-/- [46] and TLR3
-/- [47] mice and were
maintained in a-minimal essential medium (MEM) supplemented
with 10% fetal bovine serum (FBS), 100 U mL
-1 penicillin, 100 mg
mL
-1 streptomycin (pen/strep) and 2mM L-glutamine (L-glu).
RAW 264.7, a murine monocyte macrophage cell line, was kindly
provided by A. Ashkar. HEL, a primary human fibroblast cell line
was purchased from ATCC. Both RAW 264.7 and HEL cells were
grown in Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% FBS, pen/strep and L-glu. Primary lung
fibroblasts were derived from C57Bl/6 mouse lung explant
cultures, and were maintained in DMEM medium supplemented
with 20% FBS, pen/strep and L-glu. Splenocytes were identified
as the adherent cells isolated from a C57Bl/6 mouse spleen that
had been broken down by mechanical separation followed by
ACK buffer treatment to lyse contaminating red blood cells.
Splenocytes were cultured in DMEM supplemented with 20%
FBS, pen/strep and L-glu, left to adhere overnight and RNA from
adherent cells was isolated within 24h of culturing. All cells were
incubated at 37
oC in a humidified 5% CO2 incubator.
DsRNA synthesis and treatments
DsRNA synthesis, including primer sequences, has been
described previously [39]. Briefly, dsRNA was synthesized by in
vitro transcription using the Megascript RNAi kit (Ambion). 1 mgo f
PCR fragments amplified from portions of the cloned West Nile
virus (WNv) genome was used as a template. All three dsRNA
lengths (200bp, 500 bp and 1000 bp) were based from the E
protein sequence. The primers used to amplify specific genome
sequences included a T7 sequence tag used by the T7 polymerase
during dsRNA synthesis. The average length for the poly IC used
in this study was approximately 4000 bp as determined by marker
size comparison using agarose gel electrophoresis.
DsRNA treatments were performed in serum free OptiMEM
media (Gibco) for specified time periods, with the first hour
occurring in the presence of 50 mg/mL DEAE-dextran (Pharma-
cia), unless otherwise noted. DEAE-dextran is a cationic polymer
that binds negatively charged nucleic acids and enables a closer
association between the negatively charged cell membrane and the
nucleic acid of interest [48]. In all experiments, DEAE-dextran
was utilized in dsRNA-untreated controls to ensure that the
polymer alone was not influencing subsequent cellular responses.
DEAE-dextran was not used in the AcLDL binding assays, nor
when using poly IC as a competitive ligand (Figure 1).
Scavenger expression detection by RT PCR
Total RNA was isolated using the TRIzol reagent (Invitrogen,
Burlington, ON) according to manufacturer’s instruction. RNA
was DNase treated using DNA-free as per manufacturer’s
instructions (Ambion, Austin, TX). cDNA synthesis was performed
using 1 mg RNA, 0.2 ng of random 6mer primer, and 50 U of
SuperScript II reverse transcriptase (Invitrogen). Subsequent PCR
reactions were performed using 2 mL undiluted cDNA, 200nM
each primer set and 1U of Taq DNA polymerase (Invitrogen) and
PCR primers described in Table 1. All PCR products were
sequenced to confirm identity.
Fluorescence microscopy
DsRNA was labeled with Alexafluor 488 using the Ulysis
nucleic acid labeling kit (Invitrogen). Excess labeling reagent was
removed using Micro Biospin P-30 columns (BioRad, Hercules,
CA). Alexafluor 488 labeled acetylated low-density lipoprotein
(AcLDL) was purchased from Molecular Probes (Burlington,
Canada). Cells were seeded on glass coverslips and treated with
fluorescently labeled v200 (1 mg/mL), v1000 (1 mg/mL) or AcLDL
(2.5 mg/mL), with or without scavenger receptor competitive
ligands (all 100 mg/mL) or anti-SRA antibody and normal goat
serum (ngs) control (both diluted 1:50), as indicated. Following
incubations for designated time points, cells were fixed with 4%
paraformaldehyde. Nuclei were stained with Hoechst 33258
(Sigma). AcLDL binding assay were recorded as live cell images.
Images were captured using a Leica DM-IRE2 inverted
microscope.
Ligand entry assay
Cells were seeded into 96 well plates and treated the next day
with fluorescently labeled dsRNA or AcLDL for indicated lengths
of time as described in the figure legends. Total fluorescence was
measured prior to removal of unbound dsRNA. Following
incubations, unbound dsRNA was removed, cells were washed
with PBS, and 0.025% trypan blue was added to the wells to
quench extracellular, cell-associated fluorescence to measure only
intracellular fluorescence. Results were reported as a % of control
cells, equalized to each respective total fluorescence.
Endocytosis inhibitors
Cells were treated with increasing concentrations of endocytosis
inhibitors chlorpromazine hydrochloride, cytochalasin D, bafilo-
mycin A1, for 30 minutes prior to treatment with v1000 (1 mg/mL)
in combination with the inhibitors for 2h. RNA was collected and
real time PCR performed as described below. No cell death was
observed for any reported concentration of inhibitor as measured
using the fluorescent viability dyes, alamar Blue and CFDA-AM.
siRNA treatment
SR-AI/II, SCARA3, SCARA4 and SCARA5 were knocked
down individually or in combinations in balb-c MEFs using siRNA
oligomers and reverse transfection. Gene specific oligomers
(100 nM) were combined with Dharmafect1 transfection reagent
and cells were seeded on top of this combination. All experiments
were performed at 24h post transfection when optimal knockdown
was observed. Control cultures were treated with equal amounts of
a non-targeting negative control pool of oligomers.
Real time RT- PCR
For real time RT-PCR, cells were treated with dsRNA in the
presence or absence of endocytosis inhibitors, scavenger receptor
ligands, antibodies or siRNA oligomers. After specified time
points, RNA was isolated from treated MEFs using Trizol reagent
(Invitrogen) according to the manufacturer’s protocol. RNA was
DNase treated using DNA-free as per the manufacturer’s
specifications (Ambion), and then quantified using the Agilent
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RNA was reverse transcribed with 0.2 ng of random 6mer primer
and 50 U of Superscript II (Invitrogen) in a total reaction volume
of 20 mL. Real-time quantitative PCR was performed in triplicate,
in a total volume of 25 mL, using Universal PCR Master Mix and
gene specific primers (Applied Biosystems). PCR was run in the
ABI PRISM 7900HT Sequence Detection System using the
Sequence Detector Software version 2.2 (Applied Biosystems).
Data were analyzed using the DDCt method. Specifically, gene
expression was normalized to the housekeeping gene (GAPDH)
and expressed as fold change over the control group.
Animal experiments
SR-AI/II
-/- mice and wild type (WT) C57Bl/6 control mice
were used for these experiments. The age and sex-matched control
mice were purchased from Charles River Laboratories (Montreal,
PQ, Canada). Animals were anesthetized and 50 mg poly IC was
delivered intranasally in 35 ml of phosphate-buffered saline (PBS)
vehicle. Mice were sacrificed 12 hours following treatment with
poly IC. Lungs were removed, tracheas cannulated (Becton
Dickinson and Co., Sparks, Maryland, USA) and broncho-
alveolar lavage fluid (BALF) obtained by lavaging twice with
PBS (250 ml and 200 ml). BALF was stored on ice until antiviral
assays were performed as described below. Three lobes from the
multi-lobed side of the lung were minced and stored in RNAlater
(Ambion, Streetsville, Canada) at 280uC until RNA isolation and
real time PCR was performed as described above.
Antiviral assay
For BALF the antiviral assay was performed as previously
described [49]. Briefly, cells were removed from BALF samples by
centrifugation and monolayers of MEFs were incubated with serially
diluted supernatants for 24 hours in 24 well dishes. To measure the
dsRNA induced antiviral response, MEFs (WT, TLR3
-/-,T R I F
-/-,
RIGI
-/-,M D A 5
-/- IPS-1
-/-) were treated with serial dilutions of
equal nanomolar amounts of poly IC or in vitro transcribed dsRNA
(v200) for 6h. In all cases supernatants were removed and MEFs
were infected with VSV-GFP (MOI of 0.1) in serum free a-MEM
for 1h. Viral inoculate were replaced with DMEM containing 1%
methylcellulose and GFP fluorescence intensity was measured 24
hours later on a Typhoon Trio (GE Healthcare) and quantified
using the ImageQuant
TMTL software. For dsRNA responses, a dose
response curve was generated for each cell line.
Western blot analysis
For Western blot analysis, cells were washed twice in ice-cold
PBS, and collected by centrifugation at 200 xg for 4 min at 4uC.
Cell pellets were lysed in a non-reducing whole cell extract buffer
(20 nM HEPES [pH 7.4], 100 mM NaCl, 10 mM b-glycerophos-
phate, 0.2% Triton X-100, 50 nM sodium fluoride, 1mM sodium
orthovanadate, 1mM phenylmethylsulfonyl fluoride, and 1X
protease inhibitor cocktail [Sigma]), for 15 min on ice, and then
cleared by centrifugation for 10 min at 13,000 xg at 4uC. 20 mgo f
cell extract was run on 10% polyacrylamide gels, transferred onto
nitrocellulose membrane, and probed with anti-human SR-A
(1:2000). Blots were then incubated with anti-goat horseradish
peroxidase -conjugated secondary antibody and visualized using
an enhanced chemiluminescence system (ECLplus kit, GE
Healthcare).
Statistical analysis
Data are expressed as means 6 standard error of the mean
(unless otherwise indicated). Statistical analysis was performed
using a one-way analysis of variance (ANOVA) with a tukey’s post
hoc test for pair-wise comparisons, a Dunnett’s post test for
comparisons with control treatments, and an unpaired t-test in the
case of a comparison between two values. All statistical analysis
was performed using GraphPad InStat (version 3.00 for Windows
95, GraphPad Software, San Diego California USA, www.
graphpad.com). A p value of ,0.05 was considered statistically
significant.
Supporting Information
Figure S1 MEFs derived from balb-c mice bind dsRNA
similarly to C57Bl/6 MEFs. Balb-c derived MEFs were treated
for 1h with 1 mg/mL Alexfluor 488 labeled v200 or v1000 in the
presence or absence of fucoidin or fetuin (both 100 mg/mL). Cells
were fixed and nuclei were counterstained with Hoescht 33258.
Magnification 400X.
Found at: doi:10.1371/journal.ppat.1000829.s001 (0.72 MB TIF)
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